Hester Biosciences - About the company
Hester Biosciences is a public company based in Ahmedabad (India), founded in 1987 by Rajiv Gandhi. It operates as a Manufacturer of animal vaccines and healthcare products. Hester Biosciences has raised an undisclosed amount in funding. The company has 144 active competitors, including 21 funded and 23 that have exited. Its top competitors include companies like Ceva, Zoetis and Rejuvenate Bio.
Company Details
Manufacturer of animal vaccines and healthcare products. Company products include vaccines, drugs, feed supplements, and disinfectants for animals. It offers solutiotions for livestock, pet and more.
- Website
- www.hester.in/
- Social
- Email ID
- *****@hester.in
- Phone Number
- +91 **********
- Registered Address
- Village Meda-Adraj, Taluka Kadi, Mahesana, Mahesana, Mahesana, Gujarat, India, 384441
Key Metrics
Founded Year
1987
Location
Ahmedabad, India
Stage
Public
Latest Funding Round
Ranked
8th among 144 active competitors
Annual Revenue
₹100 - ₹500 Cr as on Mar 31, 2025
Employee Count
522 as on Sep 30, 2026
Exit Details
Public
Legal entities associated with Hester Biosciences
Hester Biosciences is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
HESTER AVIATION SERVICES PRIVATE LIMITED CIN: U62200GJ2019PTC106191 , India, Active | Jan 21, 2019 | 0 - ₹10 Cr (As on Mar 31, 2025) | - | |
TEXAS LIFESCIENCES PRIVATE LIMITED CIN: U24304GJ2017PTC097758 , India, Active | Jun 06, 2017 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | 48 (As on Jan 31, 2025) | |
HESTER BIOSCIENCES LIMITED CIN: L99999GJ1987PLC022333 , India, Active | Apr 29, 1987 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 633 (As on Jan 31, 2025) |
Hester Biosciences's IPO details
Hester Biosciences got listed on Aug 21, 2002.
Click here to take a look at Hester Biosciences's IPO in detail
Sign up to download Hester Biosciences' company profile
Hester Biosciences's funding and investors
Hester Biosciences has raised funding over 4 rounds. Its first funding round was on Jun 20, 2014. Its latest funding round was a Grant (prize money) round on Apr 08, 2022 for $*****. 1 investor participated in its latest round. Hester Biosciences has 3 institutional investors.
Here is the list of recent funding rounds of Hester Biosciences:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 08, 2022 | 9319254 | Grant (prize money) | 6941148 | 5802682 | 6186428 | 1149627 |
May 14, 2018 | 6178270 | Post IPO | 2784500 | 4968236 | 6766675 | |
May 14, 2018 | 7781782 | Grant (prize money) | 2630241 | 3027332 | 4903823 |
Access funding benchmarks and valuations. Sign up today!View details of Hester Biosciences's funding rounds and investors
Hester Biosciences' founders and board of directors
Founder? Claim ProfileThe founders of Hester Biosciences is Rajiv Gandhi. Rajiv Gandhi is the CEO of Hester Biosciences.
Here are the details of Hester Biosciences' key team members:
- Rajiv Gandhi: Founder & CEO of Hester Biosciences. Contact Info: 1 email address
View details of Hester Biosciences's Founder profiles and Board Members
Hester Biosciences' employee count trend
Hester Biosciences has 522 employees as of Sep 26. Here is Hester Biosciences's employee count trend over the years:
Uncover Hester Biosciences' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Hester Biosciences's Competitors and alternates
Top competitors of Hester Biosciences include Ceva, Zoetis and Rejuvenate Bio. Here is the list of Top 10 competitors of Hester Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Global animal health company providing innovative solutions for diverse animal species | $214M | 77/100 | ||
2nd |  Zoetis 2013, Parsippany (United States), Public | Global animal health company dedicated to nurturing the world through animal care | - | 74/100 | |
3rd | _1551769784760.png?devicePixelRatio=2&height=30&width=30){kind=logo} Rejuvenate Bio 2018, San Diego (United States), Series A | Developer of gene therapies for treating chronic and age-related diseases | $34M | 62/100 | |
4th |  Zenex Animal Health 2021, Ahmedabad (India), Seed | Manufacturer of veterinary drugs | $60.6K | 57/100 | |
5th |  Astra 2019, Villigen (Switzerland), Seed | Developer of small molecule anti-parasitic drugs using structural data | $9.77M | 50/100 | |
6th |  KindredBio 2012, Burlingame (United States), Acquired | Veterinary biotechnology company | $6.9M | 50/100 | |
7th | Developer of therapeutics for animal health | $2.5M | 48/100 | ||
8th | Hester Biosciences 1987, Ahmedabad (India), Public | Manufacturer of animal vaccines and healthcare products | - | 47/100 | |
9th |  Biogenesis Bagó 2005, Garin (Argentina), Unfunded | Developer of therapeutics for animal health disorders | - | - | 47/100 |
10th | RR Animal Health Care 2006, Hyderabad (India), Funding Raised | Provider of vet pharmaceutical products | - | 46/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Hester Biosciences's competitors? Click here to see the top ones
Financials of Hester BiosciencesFY 25 Available
HESTER BIOSCIENCES LIMITED, the legal entity associated with Hester Biosciences, generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2025.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 5862 | 8179 | 5163 | 2388 | 7785 |
Total Sales | 5314 | 2658 | 5084 | 6964 | 9860 |
Total Expenses | 4081 | 4778 | 3900 | 4243 | 2496 |
Operating Expenses | 9520 | 2091 | 9146 | 4431 | 4885 |
Employee Expenses | 5934 | 8751 | 4716 | 7103 | 5976 |
Marketing Expenses | 3643 | 4032 | 5630 | 2608 | 8812 |
Operating Income (EBIT) | 5151 | 9197 | 9803 | 9953 | 9232 |
Interest Expenses | 2989 | 9850 | 3406 | 4016 | 9009 |
Expenses from other activities | 7044 | 2644 | 2523 | 6114 | 8061 |
EBITDA | 3698 | 4194 | 6316 | 1119 | 7022 |
Taxes | 7472 | 6240 | 9523 | 1675 | 2829 |
Net Profit | 3875 | 9790 | 1773 | 4942 | 8985 |
Balance Sheet | |||||
Assets | 4161 | 4733 | 1530 | 6646 | 4642 |
Cash Equivalent | 1917 | 8649 | 9167 | 9039 | 8974 |
Accounts Receivables | 4724 | 9774 | 8359 | 5156 | 7285 |
Inventory | 8582 | 8346 | 2447 | 5359 | 5031 |
Liabilities | 4360 | 6162 | 7241 | 7897 | 7685 |
Total Debt | 8050 | 3391 | 8988 | 9194 | 8842 |
Accounts Payable | 8460 | 9244 | 5028 | 1399 | 4509 |
Equities | 1033 | 1669 | 3801 | 9579 | 2394 |
Cashflow Statement | |||||
Cash from Operating activities | 6085 | 9061 | 3441 | 9874 | 3184 |
Cash from Investing activities | 9632 | 4575 | 4715 | 9073 | 1118 |
Net cash from Financing activities | 9684 | 1358 | 1088 | 7278 | 4723 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Hester Biosciences's Investments and acquisitions
Hester Biosciences has made no investments or acquisitions yet.
Reports related to Hester Biosciences
Here is the latest report on Hester Biosciences's sector:
News related to Hester Biosciences
Filter this list•
Hester Biosciences Submits Business Responsibility & Sustainability Report for FY25Moneycontrol•Jul 11, 2025•Hester Biosciences
•
Hester Biosciences and Style Baazaar lead India’s stock market gainers on April 2 amid selective midcap rallyBusiness News Today•Apr 03, 2025•Hester Biosciences, Style Baazar
•
•
Hester Biosciences consolidated net profit up 6% in H1FY24Medical Buyer•Nov 07, 2023•Hester Biosciences
•
Hester Biosciences Q1FY24 Net Profit Up 88% to Rs. 6.71 CroreSMEStreet.in•Aug 09, 2023•Hester Biosciences
•
Hester Biosciences to procure technology from ICAR-NIHSAD for development of H9N2 vaccine for poultryBusiness Standard•Dec 28, 2022•Hester Biosciences, Nihsad
•
Hester Biosciences plans capacity expansion to manufacture Goat Pox VaccineIndia Infoline•Sep 26, 2022•Hester Biosciences
•
Hester Biosciences Reported Operations Revenue of Rs. 50.7 Crore in Q1FY23SMEStreet.in•Aug 11, 2022•Hester Biosciences
•
Hester Biosciences Ltd Q4 and FY22 Results Shows Consolidated Revenue Up by 10%SMEStreet.in•May 21, 2022•Hester Biosciences
•
Hester Biosciences to receive RS 60 Cr grant from BIRACBioSpectrum India•Apr 08, 2022•Hester Biosciences, BIRAC
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Hester Biosciences
Explore our recently published companies
- Lacy And Par - Tukwila based, 1984 founded, Unfunded company
- Moeheat - Santa Clarita based, 2008 founded, Public company
- Z-axis Prints - Spokane based, 2010 founded, Unfunded company
- Zen Creative Group - Portland based, 1995 founded, Unfunded company
- Rjo Ventures - North Miami Beach based, 2011 founded, Unfunded company
- Roberts Design - Las Vegas based, 2014 founded, Unfunded company
